BRIEF published on 11/13/2025 at 19:45, 4 months 9 days ago Lancement d'une augmentation de capital par MaaT Pharma Augmentation De Capital Investisseurs Qualifiés Offre Globale MaaT Pharma Xervyteg® Commercialisation
BRIEF published on 11/13/2025 at 19:45, 4 months 9 days ago MaaT Pharma launches a capital increase Capital Increase Qualified Investors MaaT Pharma Global Offer Xervyteg® Marketing
PRESS RELEASE published on 11/13/2025 at 19:40, 4 months 9 days ago Inside Information / Other news releases MaaT Pharma launches a capital increase of approximately €9 million through a private placement and PrimaryBid offering. Funds raised to support Xervyteg® commercialization and extend cash runway until summer 2026 Private Placement Investment Capital Increase MaaT Pharma Xervyteg
PRESS RELEASE published on 11/13/2025 at 19:40, 4 months 9 days ago Informations privilégiées / Autres communiqués MaaT Pharma lance une augmentation de capital de 9 millions d'euros pour financer son développement. Offre d'actions nouvelles aux investisseurs. Projets de développement clinique et commercialisation Développement Augmentation De Capital Commercialisation Actions Nouvelles MaaT Pharma
BRIEF published on 11/05/2025 at 07:35, 4 months 17 days ago MaaT Pharma dévoile des données précliniques prometteuses pour MaaT034 Immunothérapie Traitement Du Cancer MaaT Pharma Thérapie Du Microbiome MaaT034
BRIEF published on 11/05/2025 at 07:35, 4 months 17 days ago MaaT Pharma Reveals Promising Preclinical Data for MaaT034 Cancer Treatment Immunotherapy MaaT Pharma Microbiome Therapy MaaT034
PRESS RELEASE published on 11/05/2025 at 07:30, 4 months 17 days ago Inside Information / Other news releases MaaT Pharma presents updated preclinical data for MaaT034, showing immune activation and anti-tumor activity at SITC Annual Meeting. New findings enhance patient responses to immunotherapy Preclinical Data MaaT Pharma SITC Annual Meeting Immune Activation Anti-tumor Activity
PRESS RELEASE published on 11/05/2025 at 07:30, 4 months 17 days ago Informations privilégiées / Autres communiqués MaaT Pharma annonce des données précliniques actualisées pour MaaT034 au Congrès SITC, démontrant activation immunitaire et activité anti-tumorale MaaT Pharma Données Précliniques MaaT034 Activation Immunitaire Congrès SITC
BRIEF published on 11/04/2025 at 11:43, 4 months 18 days ago MaaT Pharma Receives BUY Rating from First Berlin Equity Research Biotechnology Clinical Trials Investment Cancer Treatment Microbiome Therapy
BRIEF published on 11/04/2025 at 11:43, 4 months 18 days ago MaaT Pharma reçoit une recommandation d'achat de la part de First Berlin Equity Research. Investissement Biotechnologie Essais Cliniques Traitement Du Cancer Thérapie Du Microbiome
Published on 03/20/2026 at 13:30, 2 days 8 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 9 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/22/2026 at 12:23, 9 hours 42 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 23 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 1 hour ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 2 days 1 hour ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 19:00, 2 days 3 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 3 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 3 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 3 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
